BIXT Bioxytran Inc (QB)

BIOXYTRAN, INC.

75 2^nd Ave., Ste 605

Needham, Massachusetts 02494

January 23, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporate Finance

100 F Street N.W.

Washington, D.C. 20549

Ladies and Gentlemen:

Bioxytran, Inc. (the “Registrant”) hereby respectfully submits this Delaying Amendment to the Registrant’s Registration Statement on Form S-1 (File No. 333-284415), together with all exhibits thereto, initially filed on January 22, 2025 (the “Registration Statement”).

The Company hereby inserts the “Delaying Amendment” into the Cover Page of the Registration Statement to read as follows:

“The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission acting pursuant to said section 8(a), may determine.”

If you have any questions with respect to this matter, please contact Robert J. Burnett, Witherspoon Brajcich McPhee, PLLC at (509) 455-9077.

Bioxytran (QB) (USOTC:BIXT)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025

Bioxytran (QB) (USOTC:BIXT)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025